These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11489823)

  • 21. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer.
    Xie XD; Qu SX; Liu ZZ; Zhang F; Zheng ZD
    J Cancer Res Clin Oncol; 2009 Mar; 135(3):413-9. PubMed ID: 18825410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
    Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
    Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
    Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
    J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
    Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
    Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
    J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients.
    Cohen C; Alazraki N; Styblo T; Waldrop SM; Grant SF; Larsen T
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):296-303. PubMed ID: 12607596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Breast Cancer Res Treat; 2019 Jun; 175(3):713-719. PubMed ID: 30877405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sentinel lymph node biopsy with micrometastases in breast cancer: histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification].
    Marin C; Mathelin C; Neuville A; Mertz L; Constantinesco A; Chenard MP; Bellocq JP
    Bull Cancer; 2003 May; 90(5):459-65. PubMed ID: 12850769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.
    Fox SB; Leek RD; Bliss J; Mansi JL; Gusterson B; Gatter KC; Harris AL
    J Natl Cancer Inst; 1997 Jul; 89(14):1044-9. PubMed ID: 9230886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases.
    Aranda FI; Laforga JB
    Pathol Res Pract; 1996 Feb; 192(2):124-9. PubMed ID: 8692712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.
    den Bakker MA; van Weeszenberg A; de Kanter AY; Beverdam FH; Pritchard C; van der Kwast TH; Menke-Pluymers M
    J Clin Pathol; 2002 Dec; 55(12):932-5. PubMed ID: 12461062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
    Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
    Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying tumour vascularity in non-luminal breast cancers.
    Kraby MR; Opdahl S; Akslen LA; Bofin AM
    J Clin Pathol; 2017 Sep; 70(9):766-774. PubMed ID: 28249942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.